- Familiarize learners with the significant changes in the 2022 AAP Hyperbilirubinemia Clinical Practice Guidelines Revision for Newborn Infants Greater than 35 Weeks specifically regarding risk assessment bilirubin monitoring hyperbilirubinemia treatment and post-discharge follow up.